|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Effects of telmisartan compared with eprosartan on blood pressure control,glucose metabolism and lipid profile in hypertensive,type 2 diabetic patients:a randomized,double-blind,placebo-control 12 month study显示文摘 | Derosa G Ragonesi PD Mugellini A | 2004 | Hypertens-Res2004，27，7： | 1 |
| 2 | Evaluation of the positive effects on insulin-resistance and 13-cell measurements of vildagliptin in addition to metformin in type 2 diabetic patients显示文摘 | Derosa G Ragonesi PD Carbone A | 2013 | Pharmacol Res2013，73，： | 1 |
| 3 | Effects of telmisartan compared with eprosartan on blood pressure control,glucose metabolism and lipid profile in hypertensive,type 2 diabetic patients:a randomized,double-blind,placebo-controlled 12-month study显示文摘 | Derosa G Ragonesi PD Mugellini A | 2004 | Hypertens Res2004，27，： | 1 |
| 4 | Sitagliptin added to previously taken antidiadetic agents on insulin resistance and lipid profile:a 2-year study evaluation显示文摘 | DEROSA G RAGONESI PD FOGARI E | 2012 | Fundam Clin Pharmacol2012，2，： | 1 |
| 5 | Sitagliptin added to previously taken antidiabetic agents on insulin resistance and lipid profile:a 2-year study evaluation显示文摘 | Derosa G Ragonesi PD Fogari EF | 2014 | Fundam Clin Pharmacol2014，28，2： | 1 |
| 6 | Effects of telmisartan compared with eprosartan on blood pressure control, glucose metabolism and lipid profile in hypertensive, type 2 diabetic patients: a randomized, double-blind, placebocontrolled 12 month study显示文摘 | DEROSA G RAGONESI PD MUGELLINI A | 2004 | Hypertens Res2004，27，7： | 1 |
| 7 | Sitagliptin added to previ ously taken antidiabetic agents on insulin resistance and lipid pro- file: a 2 year study evaluation显示文摘 | Derosa G Ragonesi PD Fogari E | 2014 | Fundam Clin Pharmacol2014，28，2： | 1 |
| 8 | Effects of telmisartan compared with eprosartan on blood pressure control, glucose metabolism and lipid profile in hypertensive,type 2 diabetic patients: a randomized, double-blind, placebo-controlled 12-month study显示文摘 | Derosa G Ragonesi PD Mugellini A | 2004 | Hypertens Res2004，27，： | 1 |
| 9 | Sitagliptin added to previously taken antidiabetic agents on insulin resistance and lipid profile:a 2-year study evaluation显示文摘 | Derosa G Ragonesi PD Fogari E | 2014 | Fundam Clin Pharmacol2014，28，2： | 1 |
| 10 | Evaluation of the posi- tive effects on insulin-resistance and β-cell measurements of vilda- gliptin in addition to mefformin in type 2 diabetic patients 显示文摘 | Derosa G Ragonesi PD Carbone A | 2013 | Pharmacol Res2013，73，： | 1 |
| 11 | Vildaghpfin added to met- formin on beta-cell function after a euglyccmic hypcriusulincmic and hyperglycemic clamp in type 2 diabetes patients 显示文摘 | Dcrosa G Ragonesi PD Carbone A | 2012 | Diabetes TccImol Thcr2012，14，6： | 1 |
| 12 | Vildagliptin Added to Metformin on 13-Cell Function After a Euglycemic Hyperinsulinemic and Hyperglycemic Clamp in Type 2 Diabetes Patients显示文摘 | Derosa G Ragonesi PD Carbone A | 2012 | Diabetes Technol Ther2012，14，6： | 1 |
| 13 | Effects of telmisartan comparedwith eprosartan on blood pressure contro, ! glucose metabolism and lipid profile in hypertensive, type 2 diabetic patients: a randomized, double-blind, placebo-controlled 12-month study显示文摘 | Derosa G Ragonesi PD Mugellini A | 2004 | Hypertens Res2004，27，7： | 1 |
| 14 | Effects of telmisartan compared with eprosartan on blood pressure control, glucose metabolism and lipid profile in hypertensive, type 2 diabetic palients: a randomized, double-blind, placebo-controlled 12-month study显示文摘 | Derosa G Ragonesi PD Mugellini YA | 2004 | Hypertens Res2004，27，3： | 1 |
| 15 | Effects of telmisartan compared with eprosartan on blood pressure control,glucose metabolism and lipid profile in hypertensive,type 2 di-abetic patients:a randomized double-blind,placebo-controlled 12-month study显示文摘 | DEROSA G RAGONESI PD MUGELLINI A | 2004 | Hypertens Res2004，27，7： | 1 |
| 16 | Evaluation of the positive effects on insulin-resistance and beta-cell measurements of vildagliptin in addition to metformin in type 2 diabetic patients显示文摘 | Derosa G Ragonesi PD Carbone A | 2013 | Pharmacol Res2013，73，： | 1 |
| 17 | Metabolic effects of pioglitazone and rosiglitazone in patients with diabetes and metabolic syndrome treated with metformin 显示文摘 | Derosa GD Angelo A Ragonesi PD | 2007 | Intern Med J2007，37，2： | 1 |
| 18 | Effect of telmisartan compared with eprosartan on blood pressure control, glucose metabolism and lipid profile in hypertensive, type 2 diabetic patients : a randomized, double-blind, placebo controlled 12 month study显示文摘 | Deuosa G Ragonesi PD Mugellini A | 2004 | H ypertens Res2004，27，： | 1 |
| 19 | Sitagliptin added to previously taken antidiabetic agents on insulin resis- tance and lipid profile: a 2-year study evaluation 显示文摘 | Derosa G Ragonesi PD Fogari E | 2012 | Fundam Clin Pharmacol2012，28，2： | 1 |
| 20 | Metformin-pioglitazone and metformin-msiglitazone effects on non-conventional cardiovascular risk factors plasma level in type 2 diabetic patients with metabolic syndrome显示文摘 | DEROSA G D'ANGELO A RAGONESI PD | 2006 | J Clin Pharm Ther2006，31，4： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员